SEC FORM 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:		3235-0104
Expires:	December 31, 2014
Estimated average burden
hours per response:		0.5

1. Name and Address of Reporting Person ^*

Thompson Kweli

(Last)

(First)

(Middle)

710 MEDTRONIC PARKWAY

(Street)

MINNEAPOLIS

55432

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
06/18/2026

3. Issuer Name and Ticker or Trading Symbol
Medtronic plc [ MDT ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
EVP & President, Neuroscience

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	30,017.737 ⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Performance Share Unit	⁽²⁾	⁽²⁾	Ordinary Shares	3,252.987 ⁽³⁾	⁽⁴⁾	D
Performance Share Units	⁽⁵⁾	⁽⁵⁾	Ordinary Shares	9,911.187 ⁽⁶⁾	⁽⁴⁾	D
Performance Share Units	⁽⁷⁾	⁽⁷⁾	Ordinary Shares	9,178.809 ⁽⁸⁾	⁽⁴⁾	D
Stock Option (Right to Buy)	08/01/2017⁽⁹⁾	08/01/2026	Ordinary Shares	1,704	88.06	D
Stock Option (Right to Buy)	01/30/2018⁽⁹⁾	01/30/2027	Ordinary Shares	1,608	74.67	D
Stock Option (Right to Buy)	07/31/2018⁽⁹⁾	07/31/2027	Ordinary Shares	4,407	83.97	D
Stock Option (Right to Buy)	07/30/2019⁽⁹⁾	07/30/2028	Ordinary Shares	6,271	89.08	D
Stock Option (Right to Buy)	07/29/2020⁽⁹⁾	07/29/2029	Ordinary Shares	1,615	103.26	D
Stock Option (Right to Buy)	08/03/2021⁽⁹⁾	08/03/2030	Ordinary Shares	10,181	97.33	D
Stock Option (Right to Buy)	08/02/2022⁽⁹⁾	08/02/2031	Ordinary Shares	6,358	131.26	D
Stock Option (Right to Buy)	08/01/2023⁽⁹⁾	08/01/2032	Ordinary Shares	26,890	93.08	D
Stock Option (Right to Buy)	07/31/2024⁽⁹⁾	07/31/2033	Ordinary Shares	25,408	87.76	D
Stock Option (Right to Buy)	07/29/2025⁽⁹⁾	07/29/2034	Ordinary Shares	1,540	80	D
Stock Option (Right to Buy)	07/28/2026⁽⁹⁾	07/28/2035	Ordinary Shares	22,363	91.97	D

Explanation of Responses:

1. Includes 6,549 performance stock units that vested on April 24, 2026; 1,822 restricted stock units that vested on December 6, 2025; 3,742.990 restricted stock units that vest on July 31, 2026; 3,402.644 restricted stock units that vest on December 6, 2026; 9,911.187 restricted stock units that vest on July 29, 2027; 4,589.916 restricted stock units that vest on July 28, 2028.

2. The performance share units ("PSUs") vest on December 6, 2026.

3. The number of shares to be issued in connection with the PSUs reported reflects the amount earned based on achievement of applicable performance criteria. The award remains subject to time-based vesting.

4. Each PSU represents a contingent right to receive one share of Medtronic common stock.

5. The PSUs vest on April 30, 2027.

6. The number of shares to be issued in connection with PSUs will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 9,911.187 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.

7. The PSUs vest on April 28, 2028.

8. The number of shares to be issued in connection with the PSUs will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 9,178.809 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.

9. These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.

	/s/ Patricia Walesiewicz, attorney-in-fact	06/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

EX-24